Knome Makes Genomic Interpretation Accessible to Startups by Sponsoring LabCentral

by Jason Bailey | Sep 9, 2014 | Press Releases

Knome Makes Genomic Interpretation Accessible to Startups by Sponsoring LabCentral CAMBRIDGE, Mass. – September 9, 2014 – Knome, Inc. today announced that it has entered a sponsorship agreement with LabCentral to provide the knoSYS® Informatics and Genomic...

Webinar: Toward Precision Medicine in Neurological Disease

by Jason Bailey | Sep 2, 2014 | Webinars & Event

Webinar: Toward Precision Medicine in Neurological Disease Presenter: David B. Goldstein, PhD, Director of the Center for Human Genome Variation at Duke University Date: November 13, 2014 Abstract One primary challenge in the interpretation of large-scale sequencing...

Knome Launches Major Upgrade to Its Genomic Interpretation Platform, Targets Clinical and Translational Laboratories

by Jason Bailey | Aug 12, 2014 | Press Releases

Knome Launches Major Upgrade to Its Genomic Interpretation Platform, Targets Clinical and Translational Laboratories Version 3 of the knoSYS® Platform lowers barriers to next-generation sequencing genomic testing through scalability, automation, performance, and...

Webinar: Interpreting Human Next-Gen Sequencing Data with the knoSYS® Platform

by Jason Bailey | Jul 24, 2014 | Webinars & Event

Webinar: Interpreting Human Next-Gen Sequencing Data with the knoSYS® Platform Presenter: Ben Salisbury, PhD, SVP of Clinical Products at KnomeDate: August 14, 2014 AbstractEvery week a major new genomic initiative is announced that will revolutionize healthcare....

Behind the knoSYS 100: Building the Genome Supercomputer

by Jason Bailey | Jul 22, 2014 | In The Media

Behind the knoSYS 100: Building the Genome Supercomputer The knoSYS® platform k100 model is featured in Bio-IT World as the “Genome Supercomputer.” An excerpt: In a clinical setting, processing and comparing large numbers of genomes is not as important as speed,...